论文部分内容阅读
作者回顾性分析了最近3年来所收治的100例小肝细胞癌(直径≤5cm)的存活时间与治疗方法及肝功能Child′s分级之间的关系。当只考虑主要治疗方法而不考虑疾病的分期时:手术治疗34例病人平均存活期为35.0个月;经肝内动脉插管栓塞治疗20例病人平均存活期为28.8个月;肝内动脉插管给药化疗25例其平均存活期为10.6个月;17例接受特异治疗其平均存活期为9.7个月。当不考虑治疗方法而按肝功能Child′s分级将病人分为三期;37例肝功能Child′sA级的
The authors retrospectively analyzed the relationship between the survival time and treatment of 100 cases of small hepatocellular carcinoma (≤5cm in diameter) treated in the past 3 years and the Child’s grade of liver function. When considering only the main treatment method without considering the staging of the disease: the average survival time of 34 patients treated with surgery was 35.0 months; the average survival time of 20 patients treated with intrahepatic artery catheter embolization was 28.8 months; The average survival time of tube-administered chemotherapy was 10.6 months in 25 patients, and the average survival time was 17 months in 17 patients who received specific treatment. Patients were divided into three stages according to Child’s grade of liver function when treatment was not considered; 37 cases of Child’s A grade liver function